We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
-0.06%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$60.5B
AUM Growth
+$2.39B
(+4.1%)
Cap. Flow
+$1.77B
Cap. Flow
% of AUM
2.93%
Top 10 Holdings %
Top 10 Hldgs %
17.56%
Holding
4,827
New
882
Increased
1,455
Reduced
1,567
Closed
849
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.29B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$673M |
| 3 |
VanEck Semiconductor ETF
SMH
|
+$170M |
| 4 |
Oracle
ORCL
|
+$168M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$154M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$210M |
| 2 |
UnitedHealth
UNH
|
+$158M |
| 3 |
Netflix
NFLX
|
+$140M |
| 4 |
Dollar General
DG
|
+$135M |
| 5 |
Micron Technology
MU
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.07% |
| 2 | Consumer Discretionary | 6.01% |
| 3 | Healthcare | 4.63% |
| 4 | Industrials | 4.29% |
| 5 | Financials | 4.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3776
Telos
TLS
$337M
| $107K | ﹤0.01% |
26,625
-84,847
| -76% | -$322K |
|
|
SRG
3777
Seritage Growth Properties
SRG
$130M
| $107K | ﹤0.01% |
22,808
-45,084
| -66% | -$327K |
|
3778
Relmada Therapeutics
RLMD
$544M
| $106K | ﹤0.01% |
35,425
-43,588
| -55% | -$158K |
|
3779
Ultralife
ULBI
$88.3M
| $106K | ﹤0.01% |
10,000
-3,898
| -28% | -$41.5K |
|
3780
CALL
Annexon
ANNX
$855M
| $105K | ﹤0.01% |
+21,500
| New | +$111K |
|
3781
Aclaris Therapeutics
ACRS
$730M
| $104K | ﹤0.01% |
+94,687
| New | +$111K |
|
3782
Claros Mortgage Trust
CMTG
$306M
| $103K | ﹤0.01% |
+12,873
| New | +$109K |
|
3783
Barnes & Noble Education
BNED
$412M
| $103K | ﹤0.01% |
+16,109
| New | +$558K |
|
|
BGFV
3784
DELISTED
Big 5 Sporting Goods
BGFV
| $103K | ﹤0.01% |
34,782
+10,317
| +42% | +$34K |
|
3785
Seer Inc
SEER
$108M
| $103K | ﹤0.01% |
61,237
-135,799
| -69% | -$254K |
|
3786
GDS Holdings
GDS
$6.34B
| $102K | ﹤0.01% |
11,010
-3,451
| -24% | -$27.9K |
|
|
MOMO
3787
Hello Group
MOMO
$869M
| $102K | ﹤0.01% |
+16,699
| New | +$97.5K |
|
|
ATXS
3788
CALL
DELISTED
Astria Therapeutics
ATXS
| $102K | ﹤0.01% |
11,200
-96,700
| -90% | -$944K |
|
3789
Five Point Holdings
FPH
$379M
| $102K | ﹤0.01% |
34,690
-17,057
| -33% | -$52.7K |
|
3790
Aemetis
AMTX
$119M
| $101K | ﹤0.01% |
33,713
-51,589
| -60% | -$197K |
|
|
BLUE
3791
DELISTED
bluebird bio
BLUE
| $101K | ﹤0.01% |
+5,122
| New | +$103K |
|
|
EGRX
3792
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $99.8K | ﹤0.01% |
+17,825
| New | +$77.6K |
|
3793
Acrivon Therapeutics
ACRV
$68.5M
| $99.8K | ﹤0.01% |
+17,207
| New | +$139K |
|
3794
Solid Biosciences
SLDB
$771M
| $98.6K | ﹤0.01% |
+17,389
| New | +$156K |
|
|
NFBK
3795
DELISTED
Northfield Bancorp
NFBK
| $98.6K | ﹤0.01% |
10,400
-3,153
| -23% | -$27.6K |
|
3796
CALL
Valley National Bancorp
VLY
$7.93B
| $98.4K | ﹤0.01% |
+14,100
| New | +$103K |
|
|
MREO
3797
Mereo BioPharma
MREO
$45.9M
| $98.3K | ﹤0.01% |
27,297
-20,390
| -43% | -$66K |
|
|
WW
3798
CALL
DELISTED
WW International
WW
| $97.5K | ﹤0.01% |
83,300
-52,700
| -39% | -$87.7K |
|
3799
Douglas Elliman
DOUG
$155M
| $97.4K | ﹤0.01% |
+83,951
| New | +$106K |
|
3800
BioAtla
BCAB
$5.59M
| $96.7K | ﹤0.01% |
+1,412
| New | +$168K |
|
Similar funds
Squarepoint's Q2 2024 Portfolio in Review
As of Q2 2024, Squarepoint held 4,827 positions worth $60.5B, up 4.1% from $58.1B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Squarepoint's Q2 2024 filing shows 882 new, 1,455 increased, 1,567 reduced and 849 closed positions. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 1,286,013 shares worth $700M. The largest sale was Apple, an estimated $210M.
By sector, the portfolio is most concentrated in Technology at 9.1% of assets, up from 8.5% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Squarepoint's largest Q2 2024 buy was State Street SPDR S&P 500 ETF Trust: 1,286,013 shares worth $700M.
- Squarepoint added most to iShares Core S&P 500 ETF in Q2 2024, an estimated $1.29B increase.
- Squarepoint's biggest Q2 2024 reduction was Apple, cutting an estimated $210M.
- Squarepoint fully exited DraftKings in Q2 2024, selling an estimated $94.6M.
- Squarepoint's ten largest holdings make up 18% of its $60.5B portfolio in Q2 2024.
- Squarepoint opened 882 new positions and closed 849 in Q2 2024.
- Squarepoint's portfolio value rose 4.1% quarter-over-quarter to $60.5B.
Based on Squarepoint's 13F filing for Q2 2024, filed 14 Aug 2024.